Targeting inflammation to slow or delay functional decline: where are we?
Authors: Corsonello A, Garasto S, Abbatecola AM, Rose G, Passarino G, Mazzei B, Pranno L, Guffanti EE, Bustacchini S, Lattanzio F
Date: 2010
Scope of interest: biogerontology
06 99 39
Recup number
You may also be interested in:
Intravenous administration of Rituximab in the treatment of Primary Cutaneous B-Cell Lymphomas (PCBCLs): a retrospective study
Authors:
Date: 2014
Scope of interest: Haematology
Read details
” Use of hyperimmune plasma for compassionate use in patients with Marginal Non-Hodgkin Lymphoma persistently positive for SARS CoV-2 infection”
Authors: C.D'Amico - F. De Angelis - F.Docimo – C.Gargiulo
Date: 2022
Scope of interest: CLINICAL PATHOLOGY
Read details
From Italy to Saint Louis: Adaptin to COVID-19
Authors: Abatecola Angela Marie
Date: 2020
Scope of interest: Covid-19
Read details
What to do to
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide
